Angiopoietin-2 Causes Pericyte Dropout in the Normal Retina: Evidence for Involvement in Diabetic Retinopathy

Diabetes

Volumn 53, Issue 4, 2004, Pages 1104-1110

  Hammes, Hans Peter ^a   Lin, Jihong ^a   Wagner, Patrick ^b   Feng, Yuxi ^a   Vom Hagen, Franziska ^a   Krzizok, Thomas ^c   Renner, Oliver ^d   Breier, Georg ^b   Brownlee, Michael ^e   Deutsch, Urban ^b,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b M P Inst for Physiol/Clin Res   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; HETEROZYGOSITY; MALE; MORPHOMETRICS; NONHUMAN; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; RETINA CAPILLARY; UPREGULATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BETA-GALACTOSIDASE; BLOOD GLUCOSE; BODY WEIGHT; CAPILLARIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; HEMOGLOBIN A, GLYCOSYLATED; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PERICYTES; RATS; RATS, WISTAR; RETINAL VESSELS;

EID: 12144286666     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.4.1104     Document Type: Article

References (46)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY: Global data on blindness. Bull World Health Organ 73:115-121, 1995
2. Moss SE, Klein R, Klein BE: Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101:1061-1070, 1994
3. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets, DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
5. Kohner EM, Henkind P: Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 69:403-414, 1970
6. Bresnick GH, Engerman R, Davis MD, de Venecia G, Myers FL: Patterns of ischemia in diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 81:694-709, 1976
7. Klinghoffer RA, Mueting-Nelsen PF, Faerman A, Shani M, Soriano P: The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell 7:343-354, 2001
8. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C: Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17:1835-1840, 2003
9. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand SJ, Yancopoulos GD, Nishikawa S: Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 110:1619-1628, 2002
10. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U: Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51:3107-3112, 2002
11. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180, 1996
12. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169, 1996
13. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74, 1995
14. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8:529-532, 1998
15. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997
16. Hanahan D: Signaling vascular morphogenesis and maintenance. Science 277:48-50, 1997
17. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362, 1999
18. Carmeliet P: Angiogenesis in health and disease. Nat Med 9:653-660, 2003
19. Jain R: Molecular regulation of vessel maturation. Nat Med 9:685-693, 2003
20. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A 88:11555-11558, 1991
21. Hammes HP, Weiss A, Fuhrer D, Kramer HJ, Papavassilis C, Grimminger F: Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids. Diabetologia 39:251-255, 1996
22. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 3:411-423, 2002
23. Enge M, Bjarnegård M, Gerhardt H, Gustafsson E, Kalén M, Asker N, Hammes HP, Shani M, Fässler R, Betsholtz C: Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 21:4307-4316, 2002
24. Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro PA: Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol 184:275-284, 2000
25. Hohman TC, Nishimura C, Robison WG Jr.: Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp Eye Res 48:55-60, 1989
26. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150:523-531, 1997
27. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA: Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. Exp Eye Res 57:723-735, 1993
28. Sims DE: The pericyte: a review. Tissue Cell 18:153-174, 1986
29. Lyons TJ, Li W, Wojciechowski B, Wells-Knecht MC, Wells-Knecht KJ, Jenkins AJ: Aminoguarddine and the effects of modified LDL on cultured retinal capillary cells. Invest Ophthalmol Vis Sci 41:1176-1180, 2000
30. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M: Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241-2248, 2002
31. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO: Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 100:10623-28, 2003
32. Matsumara T, Hammes HP, Thornalley P, Edelstein D, Brownlee M: Hyperglycemia increases angiopoietin-2 expression in retinal Muller cells through through superoxide-induced overproduction of a-oxoaldehyde age precursors (Abstract). Diabetes 49 (Suppl. 1):A55, 2000
33. Mandriota SJ, Pepper MS: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83:852-859, 1998
34. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274:15732-15739, 1999
35. Yuan HT, Yang SP, Woolf AS: Hypoxia upregulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int 58:1912-1919, 2000
36. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
37. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
38. Giardino I, Edelstein D, Brownlee M: Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes. J Clin Invest 94:110-117, 1994
39. Umeda N, Ozaki H, Hayashi H, Miyajima-Uchida H, Oshima K: Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity. Ophthalmic Res 35:217-223, 2003
40. Hackett SF, Wiegand S, Yancopoulos G, Campochiaro PA: Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol 192:182-187, 2002
41. Lobov IB, Brooks PC, Lang RA: Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 99:11205-11210, 2002
42. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G: Upregulation of the VEGF/VEGF-receptor system in experimental background diabetic retinopathy of the rat. Diabetes 47:401-406, 1998
43. Benjamin LE, Hemo I, Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598, 1998
44. Gerhardt H, Betsholtz C: Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15-23, 2003
45. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E: Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159-165, 1999
46. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M: Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112:1049-1057, 2003